Ipatasertib

Active substance

 Ipatasertib (MO40153)

Holder

 Roche

Status

Closed

Indication

 in combination with paclitaxel in PIK3CA/AKT1/PTEN altered, locally advanced or metastatic, triple-negative breast cancer or hormone-receptor-positive, HER2-negative breast cancer

Public documents

Approbation

Information for the patient

Informed consent

Last update

24/09/2020
Last updated on